Not applicableStudy completedNCT03422263What this trial is testingPerformance Under SGLT-2-Inhibitors in HumansWho this might be right forDiabetes Mellitus, Type 2 Berner Klinik Montana 450
Not applicableLooking for participantsNCT06090591What this trial is testingCardiology Research Dubrava Prospective RegistryWho this might be right forHeart FailureArrhythmias, CardiacAtrial Fibrillation+1 more University Hospital Dubrava 3,000
Testing effectiveness (Phase 2)Study completedNCT04911660What this trial is testingImpact of the SGLT2 Inhibitor Empagliflozin on Urinary Supersaturations in Kidney Stone FormersWho this might be right forKidney Stone Insel Gruppe AG, University Hospital Bern 50
Large-scale testing (Phase 3)Active Not RecruitingNCT06297603What this trial is testingEffect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3)Who this might be right forType 2 Diabetes Eli Lilly and Company 320
Testing effectiveness (Phase 2)Study completedNCT06888505What this trial is testingDapagliflozin to Prevent Anthracycline-Induced CardiotoxicityWho this might be right forAnthracyclines-Induced CardiotoxicityCardiotoxicity Hawler Medical University 94
Not applicableLooking for participantsNCT07237451What this trial is testingCardiovascular and Renal Endpoints With Flozins - an Observational Prospective Study in CKD HFpEF PatientsWho this might be right forCKD - Chronic Kidney DiseaseHeart Failure Preserved Ejection FractionSGLT2 Inhibitors+1 more Grigore T. Popa University of Medicine and Pharmacy 200
Post-approval studies (Phase 4)Study completedNCT04778787What this trial is testingSodium-glucose Cotransporter Type 2 Inhibitors for Acute Cardiorenal Syndrome PreventionWho this might be right forCongestive Heart Failure I.M. Sechenov First Moscow State Medical University 370
Post-approval studies (Phase 4)UnknownNCT05584319What this trial is testingEMPAGUM: Effects of Empagliflozin on Gut Microbiota in Heart Failure With a Preserved Ejection FractionWho this might be right forHeart FailureHeart Failure With Preserved Ejection Fraction Zhijun Sun 100
Large-scale testing (Phase 3)WithdrawnNCT07057479What this trial is testingPhase III Trial of SGLT2 Inhibitor and Thiazolidinedione Fixed-Dose Combination vs. Monotherapy in Type 2 Diabetes Patients on MetforminWho this might be right forType 2 Diabetes Mellitus (T2DM) Eurofarma Laboratorios S.A.
Post-approval studies (Phase 4)Looking for participantsNCT04899479What this trial is testingPeri-treatment of SGLT-2 Inhibitor on Myocardial Infarct Size and Remodeling Index in Patients With Acute Myocardial Infarction and High Risk of Heart Failure Undergoing Percutaneous Coronary InterventionWho this might be right forAcute Myocardial InfarctionHeart Failure Samsung Medical Center 200
Large-scale testing (Phase 3)Study completedNCT07344922What this trial is testingSGLT2 Inhibitors in Non-Diabetic CKD: Effects on Vascular Calcification and AnemiaWho this might be right forChronic Kidney DiseaseAnemiaCardiovascular Calcification Mansoura University 100
Post-approval studies (Phase 4)UnknownNCT05225077What this trial is testingShort-term Use of Dapagliflozin to Protect Kidney Function in CKD PatientsWho this might be right forRenal Insufficiency, ChronicCardiac CatheterizationPercutaneous Coronary Intervention Dong-A University 600
Testing effectiveness (Phase 2)Study completedNCT01022112What this trial is testingAn Efficacy, Safety, and Tolerability Study for TA-7284 in Patients With Type 2 DiabetesWho this might be right forType 2 Diabetes Mellitus Tanabe Pharma Corporation 383
Large-scale testing (Phase 3)Study completedNCT05283057What this trial is testingEmpagliflozin in Patients With GlomerulonephritisWho this might be right forGlomerulonephritisProteinuria Kasr El Aini Hospital 50
Not applicableNot Yet RecruitingNCT07360457What this trial is testingGLP1 Analogues and the Risk of OsteoarthritisWho this might be right forOsteoarthritis Beni-Suef University 390
Not applicableUnknownNCT06007157What this trial is testingSodium Glucose Cotransporter-2 Inhibitors and Salt-sensitivity in Type 2 DiabetesWho this might be right forBlood PressureSalt; ExcessDiabete Type 2 Azienda Ospedaliero, Universitaria Pisana 30
Post-approval studies (Phase 4)UnknownNCT02528019What this trial is testingMetabolic and Cardiovascular Effects of Dipeptidyl Peptidase-4 (DPP-4) or Sodium-glucose Co-transporter Type 2 (SGLT2) InhibitorsWho this might be right forEffects of the DPP-4 Inhibitors or SGLT2 Inhibitors on the Protective Actions for Diabetic Complications Kurume University 100
Testing effectiveness (Phase 2)Looking for participantsNCT07239011What this trial is testingDapagliflozin in DepressionWho this might be right forDepression Tanta University 60